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Background: Hypodontia, the congenital absence of one or a few teeth is one of the most common alterations of
the human dentition. Familial hypodontia is caused by mutations in PAX9, Msx1 and Axin2 genes. Limited numbers
of studies are present to show etiological factors beyond this anomaly in Turkish community belonging to
Caucasian racial family. The purpose of this study is to investigate the relationships between the two different
single nucleotide polymorphisms that are G-1031A and T-912C with hypodontia in Caucasians.
200 individuals having hypodontia and 114 normal individuals having all 32 teeth present were selected for the
study. Blood samples were collected from each individual and DNA was extracted. To determine the
polymorphisms, PCR-RFLP method was used.
Results: The outcomes suggest that the individuals having AC haplotype carry less risk in having hypodontia
compared with the rest of the haplotype groups (OR = 3.88; CI = 95%; p = 0.001). The ratio of GT haplotype is less in
the hypodontia group meaning that the GT carriers are in risk group in terms of hypodontia risk.
Conclusion: These results indicate that polymorphisms in the promoter region of PAX9 gene may have an
influence on the transcriptional factors and activity of this gene and are associated with hypodontia in Caucasian
individuals.
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Teeth are an important part of the digestive system.
There are more than 200 genes in the control mechan-
ism of tooth development [1]. The majority of those
genes are integrated with conserved signaling pathways
mediating cellular activity, in particular between epithe-
lial and mesenchymal tissues [2]. If a problem occurs re-
lated to these genes, the pathway may be blocked and
tooth, which is the outcome of the signaling cascade,
may not be acquired.
Congenital tooth agenesis can be found in many pa-
tients during dental practices, and the prevalence of
tooth agenesis can be between 0.027% [3] and 11.3% [4].
The most frequent missing teeth are third molars, with a
prevalence of 15–20% of patients [5]. The etiology of* Correspondence: erenisman@hotmail.com
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reproduction in any medium, provided the orcongenital tooth agenesis is complex and is not clearly
known, but generally it can be attributed to genetic and
environmental factors [6]. Developmental anomalies,
endocrine tissue disorders, oral cavity originated path-
ologies, trauma to head and neck region, medical therap-
ies, early received radiotherapy, high fever, wrong
nutrition in pregnancy, and rubella-type diseases can be
considered as environmental factors [7-10].
Genetically, tooth agenesis can be either syndromic or
non-syndromic. The most recent studies show that
MSX1 [11], PAX9 [12,13], AXIN2 [14], TGFA [15], IRF6
[16], MMP1 and MMP20 [17], AXIN2 [18] and FGF3
[19] genes are related to sporadic type tooth agenesis.
Peters [20] declared that mice having a mutated PAX9
gene can show craniofacial abnormalities, extremity
anomalies, and teeth developmental problems, such as
halted tooth development during the bud phase. He
added that all the members of a family having a frame-
shift mutated PAX9 gene had missing permanent firsttd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Dentition profiles and genotypes of first twenty five patients out of 200 individuals suffering tooth agenesis
(dark background refers to maxillary teeth and white background refers to mandibular teeth)
G-1031A C-912 T Patient.# 8R 7R 6R 5R 4R 3R 2R 1R 1L 2L 3L 4L 5L 6L 7L 8L
GG CC Upper 1 X
Lower
GA CT Upper 2 X X
Lower
GA CT Upper 3 X
Lower X X
GA CT Upper 4
Lower X
GA CT Upper 5 X
Lower X
GG CC Upper 6 X X
Lower X X
GG CC Upper 7 X
Lower
GA CT Upper 8 X
Lower X X
GA CC Upper 9
Lower X
GA CT Upper 10
Lower X X
GA CT Upper 11 X X X X X X
Lower X X X X X X X
GA CT Upper 12 X
Lower
GA CT Upper 13 X X
Lower X X
GG CC Upper 14 X X
Lower
GG CC Upper 15 X X
Lower
GA CT Upper 16
Lower X X
GG CC Upper 17 X X X X
Lower X X
GG CC Upper 18
Lower X
GA CT Upper 19 X
Lower
GG CC Upper 20 X X
Lower
GG CT Upper 21 X X
Lower
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Table 1 Dentition profiles and genotypes of first twenty five patients out of 200 individuals suffering tooth agenesis
(dark background refers to maxillary teeth and white background refers to mandibular teeth) (Continued)
GG CC Upper 22
Lower X X
GA CT Upper 23
Lower X X X X
GA CT Upper 24 X X
Lower X X
GG CC Upper 25 X X
Lower
( X ) refers to missing teeth.
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erly positioned.
The expression of PAX9 also modulates the expression
of other crucial developmental regulatory genes, such as
MSX1 and Bmp4, and antagonistic interactions between
FGF8 and BMP2 or BMP4 control the initiation of PAX9
expression in mandibular mesenchyme [21].
Genetic polymorphisms often show ethnic variation.
Alleles, which are elements of a number of alternative
forms of the same gene or same genetic locus (the spe-
cific location of a gene or DNA sequence on a chromo-
some) for a character producing different effects, may
play role in this issue. For example, the frequency of the
variant allele [ G (guanine) ] allele of rs2073244 (aden-
ine) A > G was 25% in a Brazilian population [22] but
48% in a Chinese population [23]. Some studies have
noted the prevalence of congenital missing teeth in a
Turkish population [24], and limited studies could be
found about the genetic background of hypodontia in a
Turkish community which belongs to Caucasians
[16-19]. As studies of different ethnic populations are
needed to ascertain the association between genetic poly-
morphisms of PAX9 and sporadic tooth agenesis [23], theFigure 1 Genotypes generated from 202 bp PCR product acquired fro
restriction enzyme. The lanes 1, 2, 3, 7, 8: GA heterozygote; lanes 4 and 6purpose of this study was to investigate the relationship
between two different single nucleotide polymorphisms
(G-1031A and T-912C) (NCBI ref SNP ID: rs 2073247
and rs 2073244) of the PAX9 gene promoter region and
hypodontia in a Turkish population which is a member
of Caucasian racial family.
Results and discussion
Dentition profiles and genotypes of cases
The permanent dentition profile of the individuals suf-
fering from different types of tooth agenesis and their
genotypes of the PAX9 -1031 and −912 promoter re-
gions are shown in Table 1.
Product of PCR–restriction fragment length
polymorphism gel electrophoresis
Photographs of gel products obtained from restriction
enzyme digestion with the restriction fragment length
polymorphism (RFLP) technique for each polymorphic
site are given in Figure 1 and Figure 2. Analyses of the
polymorphic sites and of groups with various missing
teeth with different combinations were performed. After
the PCR and enzyme digestion analysis, the ratio of “A”m 8 individuals using spasific primers after digested with Bsn I
: GG genotype; lane 5: AA genotype; lane 9: 100 bp marker.
Figure 2 Genotypes generated from 202 bp PCR product acquired from 8 individuals using spasific primers after digested with Tru I
restriction enzyme. Lane 2: CT heterozygote; lanes 1, 4, 5, 6, 7: CC genotype; lanes 3, 8: TT genotype; lane 9: 100 bp marker.
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was found to be 34.75% in the hypodontia group, 37.70%
in the third molar agenesis group, 31.60% in the hypo-
dontia group except the third molars, and 35.50% in the
control group (Table 2). There was no statistically signifi-
cant difference found between groups. Moreover, the ra-
tio of the G allele was found to be 64.50% in the control
group, 65.25% in the hypodontia group, 62.30% in the
third molar agenesis group, and 68.40% in the hypodontia
group except the third molars (Table 2). There was no
statistically significant difference between these groups.
As shown in Table 2, we found no significant differ-
ence between the control and test groups in either
the −1031 site or the −912 site in terms of gene alleles
and their distribution to different groups of agenesis
(p > 0.05). Table 3 shows the haplotype frequency of the
PAX9 gene in the control and test groups. The haplotype
distribution of both polymorphic sites was consistent
with Hardy–Weinberg equilibrium (p > 0.09). When
haplotypes as alleles were compared, statistically signifi-
cant differences were found between the control and test
groups (p = 0.05). When compared with other groups,
the ratio of individuals having the AC haplotype was
found to be less than control groups in congenitally
tooth agenesis cases (OR = 3.88; CI = 95%; p = 0.001). It
was noticed that in the test group, the individuals having
the GT haplotype were less than any other group (OR =
0.67; CI = 0.458–0.993%; p = 0.045). No differences be-
tween control and test groups were found when haplo-
types were organized as genotypes (p = 0.622). It was
noticed that the AC/GC haplotype group was found
three times more often in the test group than the con-
trol group, but this was not significant (p > 0.05).
A comparison of the genotype variations of poly-
morphic sites with various congenitally missing teethgroups is shown in Table 4. Statistical analysis showed
that there was no relationship between tooth agenesis
groups and genotypic polymorphism variations (p =
0.171). The G-1031A polymorphism and C-912 T poly-
morphisms were then compared separately with tooth
agenesis groups, and the results of this comparison are
shown in Table 5. We found no significant relationship
between the C-912 T polymorphism and the tooth agen-
esis group (p = 0.158); a correlation was detected between
the G-1031A polymorphism and congenitally missing
teeth (p = 0.026) (Table 5).
We examined two mutagenic regions (polymorphic
sites) of the PAX9 gene, which were responsible for acti-
vating the protein synthesis process. The first mutation
described in the human PAX9 gene was a guanine inser-
tion to the 219th nucleotide in the second exon of
chromosome 14 of an oligodontia family [25]. Since this
finding, many mutations and one locus deletion of the
PAX9 gene have been reported [12,22,26]. Most of the
mutations are located in the paired domain of the second
exon.
In our study, two polymorphic regions were exam-
ined. No differences were found between the control
and hypodontia groups for the A or G alleles (p >
0.05) (Table 2). Our findings are not consistent with
the findings of Peres and co-workers [22] as their
outcomes showed a high frequency of guanine and
thymine alleles in the hypodontia group. Following
this, GG (1031) and TT (912) homozygous genotypes
were compared between the control and test groups,
and no differences were encountered (Table 2). These
results are consistent with the findings of Pan et al.
[23] but in contrast with Peres et al’s. The reason for
this may be due to the adjacency of the Turkish
and Chinese populations in terms of geographical
Table 2 Distribution of allels and genotypes of PAX9 control and test groups
SNP Control Group Hypodontia (All) Third Molar Hypodontia Excluding Third molars
n % n % n % n %
G-1031A Allel
A 81 35.5 139 34.75 77 37.7 62 31.6
G 147 64.5 261 65.25 127 62.3 134 68.4
p* 0.913 0.705 0.458
OR (%95 CI) 1.03 0.908 1.191
Genotype
AA 12 10.5 15 7.5 7 6.8 8 8.2
GA 57 50 109 54.5 63 61.7 46 46.9
GG 45 39.5 76 38 32 31.5 44 44.9
p# 0.579 0.207 0.676
Genotype
AA 12 10,5 15 7.5 7 7.7 8 8.1
GA/GG 102 89.5 185 92.5 85 92.3 90 91.9
p* 0.477 0.633 0.725
OR (%95 CI) 1.45 1.428 1.323
GA 57 35.8 109 37 63 42.5 46 33.8
GG/AA 102 64.2 185 63 85 57.5 90 66.2
p* 0.876 0.276 0.809
OR (%95 CI) 0.948 0.753 1.093
C-912 T Allels
T 81 35.5 136 34 79 38.3 58 29.5
C 147 64.2 264 66 127 61.7 138 70.5
p* 0.765 0.611 0.232
OR (%95 CI) 1.06 0.885 1.311
Genotype
TT 14 12.2 19 9.5 11 10.6 8 8.1
CT 53 46.4 98 49 57 55.3 42 42.8
CC 47 41.4 83 41.5 35 34.1 48 49.1
p# 0.730 0.426 0.423
Genotype
TT 14 12.2 19 9.5 11 10.6 8 8.1
CT/CC 100 87.8 181 90.5 92 89.4 90 91.9
p# 0.561 0.876 0.451
OR (%95 CI) 1.373 1.171 1.575
CT 53 46.4 98 49 57 55.3 42 42.8
TT/CC 61 53.6 102 51 46 44.7 56 57.2
p* 0.756 0.244 0.695
OR (%95 CI) 0.904 0.701 1.158
SNP single nucleotide polymorphism, OR odds ratio, CI confidence ınterval.
*, Chi square test P value.
#, Normal SPSS test.
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nated maternally from Amerindians and paternally
from Portuguese [28].Our study comprised third molar agenesis cases, and
we consequently found no significant difference between
the control and test groups on the basis of alleles or
Table 3 Haplotype frequency of PAX9 gene in control and test groups
Haplotype G-1031A/C-912 T Control Group Test Group p-Value
n % n % OR (CI %)
Allel
AC 55 54,5 46 45,5 0.05 (CS)
GT 55 34,8 103 65,2
GC 100 35,7 180 64,3
AT 67 37,2 113 62,8
AC 55 31.1 46 10.4 0.001( CS)
GT + GC + AT 122 68.9 396 89.6 3.88 ( OR) CI (2,49 – 6,03)
AC + GC + AT 122 68.9 339 76.6 0.05 (CS)
GT 55 31.1 103 23.4 0.673 ( OR) CI (0,458 – 0,993)
Genotype
GT/GT 0 0 0 0 0,622 (CS)
AT/GC 53 43.4 94 43.1
AC/AC 0 0 1 0.4
AC/GC 2 1.6 10 4.5
AT/GT 2 1.6 5 2.3
AC/GT 53 43.4 94 43.1
AT/AC 0 0 0 0
AT/AT 12 9.9 14 6.4
AC/GT 53 43,4 94 43,1 0.926 (CS)
GT/GT + AT/GC + AC/GC + AT/GT + AC/GT + AT/AC + AT/AT 69 56,6 125 56,9
OR odds ratio, CI confidence interval, CS chi-square.
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significant relationships for these criteria. In addition,
they also investigated the third molar excluded groups
and found that these agenesis types were related to het-
erozygosis phenotypes. In fact, human family analysis re-
vealed that PAX9 mutations have a strong connection
with third molar agenesis, indicating that PAX9 muta-
tions have a lesser but distinct effect on incisors and
premolars.
In our study, the haplotype frequencies of genotypes
and their relationship with the patient and control
groups were also examined. GT, GC, and AT alleles seen
in cases of patients with congenital missing teeth were
found to be a significant risk. In other words, the indi-
viduals having an AC allele were found to have a lower
risk of facing tooth agenesis (p ≤ 0.05). We conclude that
no relationship exists between the AC haplotype and
tooth agenesis. In parallel with this finding, when com-
paring the AC allele with GT, GC, and AT alleles, the
risk of missing teeth in individuals having an AC allele is
3.88 times lower than individuals having other alleles
(OR = 3.88; CI = 2.49–6.03%; p ≤ 0.001). The ratio of the
GT haplotype in the control groups was significant. It
is possible that subjects having this allele have a low
risk of tooth agenesis (OR = 0.674; CI = 0.458–0.993%;p = 0.045). The findings of Peres et al. were consistent
with the present study. After examining the two related
polymorphic sites, compared to the GA and AA geno-
types, the GG genotype was seen less in the third molar
missing group but there was higher frequency in groups
missing lower and upper canines, upper central incisors,
and lower and upper second molars (p = 0.026). Thus,
we conclude that individuals with a GG genotype are
unlikely to show a lack of congenital third molars and
are likely to show a lack of canines, first and second mo-
lars, and upper central incisors. However, it is not pos-
sible to infer this for T-912C (p > 0.05).
The discrepancy of the results between the studies
may be explained as follows. As demonstrated in our
study, genetic polymorphisms often show ethnic vari-
ation. For example, in the study of Peres and colleagues
on the G-1031A polymorphism, the G allele frequency
was 25%, but in our study this frequency was 65.25%.
According to the study of Pan et al. (2008), this fre-
quency value was 48%. Thus, further studies of different
ethnic populations are needed to illuminate the exact re-
lationship between the PAX9 gene polymorphism and
congenital tooth agenesis. The second reason is that the
diversity of missing teeth phenotypes of patients may
give rise to different outcomes. For example 70% of
Table 4 The comparison of the genotype variations of G-1031A and T-912C polymorphic sites of PAX9 promoter region
with various congenitally missing teeth groups
Congenitally missing teeth groups Total
12-22 14-24 15-25 35-45 31-32- 41-42 18-28- 38-48 other
GGCC 57 26 12 41 26 82 52 296
19,3% 8,8% 4,1% 13,9% 8,8% 27,7% 17,6% 100%
GGCT 6 1 0 0 0 1 0 8
75% 12,5% 0% 0% 0% 12,5% 0% 100%
GGTT 0 0 0 0 0 0 0 0
0% 0% 0% 0% 0% 0% 0% 100%
GACC 6 2 1 10 2 11 0 32
18,8% 6,3% 3,1% 31,3% 6,3% 34,4% 0% 100%
GACT 56 18 13 50 40 124 33 334
16,8% 5,4% 3,9% 15% 12% 37,1% 9,9% 100%
GATT 4 3 2 4 4 11 4 32
12,5% 9,4% 6,3% 12,5% 12,5% 34,4% 12,5% 100%
AACC 2 0 0 0 0 0 0 2
100% 0% 0% 0% 0% 0% 0% 100%
AACT 0 0 0 0 0 0 0 0
0% 0% 0% 0% 0% 0% 0% 100%
AATT 7 3 2 10 5 22 8 57
12,3% 5,3% 3,5% 17,5% 8,8% 38,6% 14% 100%
TOTAL 138 53 30 115 77 251 97 761
18,1% 7% 3,9% 15,1% 10,1% 33% 12,7% 100%
P = 0,171 (X2 test)
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whereas this percentage was 55% in our study. Pan (2008)
had excluded the third molars. We suggest that this di-
versity may disappear if future studies are based on geno-
types of different populations with the same missing
teeth groups. Past studies have contributed a great deal
to our knowledge about the process of congenital missing
teeth. However, the molecular mechanism underlying
this abnormality is still not fully described. The mismatch
between high incidences of tooth agenesis with low-value
findings of agenesis studies [15,29,30] suggest that con-
genital lack of teeth may be a more heterogeneous struc-
ture than expected and several independent defective
genes working in parallel or in combination with other
genes can lead to the formation of specific phenotypes.
For the Turkish population, limited number of studies
investigating the genetic etiology of congenital missing
teeth anomaly was found. To understand the molecular
basis of tooth agenesis, to investigate the variations of
different populations, and to explain the relationship be-
tween genetic variants and variable phenotypes clearly,
further studies should analyze both the PAX9 gene and
the other candidate genes, by increasing the sample sizeand using the latest laboratory techniques that are
proven to give more definitive results. In order to de-
velop the curing techniques and connect these results
with contemporary medical treatment alternatives in the
future, investigators dealing with tooth agenesis may
think of gathering samples from oral tissues and build
the studies up to the tissue-like structures and engineer-
ing methods which might be one of the highest limita-
tions of these kinds of studies in addition with gathering
ethical approval for both animal and human studies.
Conclusions
Our study revealed that (1) in the PAX9 gene, no signifi-
cant relationship between the hypodontia group and the
control group was found in terms of both the A or G al-
lele in the G-1031A polymorphic site; (2) the risk of
missing teeth in individuals having the AC allele is 3.88
times lower than individuals with other alleles; (3) indi-
viduals having the GG genotype have a low risk of third
molar agenesis; (4) the subjects having the GT allele can
be assumed to have a low risk of tooth agenesis; (5)
polymorphisms in the promoter region of the PAX9
gene may have an influence on hypodontia in humans.
Table 5 The relationship between polymorphisms on G-1031A and C-912 T regions and missing teeth groups
separately
Congenitally missing teeth groups Total
12-22 14-24 15-25 35-45 31-32-41-42 18-28-38-48 other
GG 63 27 12 41 26 84 52 305
20,7% 8,9% 3,9% 13,4% 8,5% 27,5% 17% 100%
GA 66 23 16 64 36 165 37 407
16,2% 5,7% 3,9% 15,7% 8,8% 40,5% 9,1% 100%
AA 9 3 2 10 5 22 8 59
15,3% 5,1% 3,4% 16,9% 8,5% 37,3% 13,6% 100%
TOTAL 138 53 30 115 67 271 97 771
18,1% 17,9% 6,9% 3,9% 14,9% 8,7% 35,1% 100%
P = 0,026
CC 63 28 13 51 28 93 52 328
%19,2 %8,5 %4 %15,5 %8,5 %28,4 %15,9 %100
CT 62 19 13 50 40 1134 33 351
%17,7 %5,4 %3,7 %14,2 %11,4 %38,2 %9,4 %100
TT 11 6 4 14 9 33 12 89
%12,4 %6,7 %4,5 %15,7 %10,1 %37,1 %13,5 %100
TOTAL 138 53 30 115 67 271 97 771
%17,7 %6,9 %3,9 %15 %10 %33,9 %12,6 %100
P = 0,158
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Patient selection and control group
Inclusion criteria were as follows:
1. All patients having hypodontia were between 12 and
32 years of age and every non-missing permanent
tooth was apparent in panoramic X-rays, including
third molars and/or their germs.
2. Patients and families were off systemic diseases and
hereditary abnormalities.
3. Spaces in the arches of patients were only from
deciduous teeth.
4. Patients having doubts about the extraction history
were excluded.
Two hundred patients meeting these criteria were
chosen for the study group. The control group was orga-
nized according to these criteria:
1. Subjects must have proper tooth number and shape.
2. Thirty-two teeth must be properly seen in
panoramic radiographs.
3. Subjects must be genetically and hereditarily healthy.
One hundred and fourteen controls were included. All
received detailed clinical, intra/extra oral, radiological
examination. General characteristics including age,gender, ethnicity, health status, birth defects, and family
history, were documented. Subjects declared that their
ancestors were Turkish. Two milliliters of venous blood
samples were collected in EDTA (Ethylenediaminetetra-
acetic acid - an anticoagulant for blood samples-) tubes
from these 314 subjects.
Ethical approval
The study design was approved by Selcuk University
Faculty ofDentistry EthicalCommittee (ApprovalNumber:
228; 2007,13–1). Informed consent was prepared and
signed by every patient participating in the study or in the
case of children, by the parents or legal guardians.
DNA isolation and polymerase chain reaction (PCR)
DNA was extracted using a special isolation kit
(UltraCleanTM DNA BloodSpin Kit; Mobio Lab Inc.,
Carlsbad, CA, USA). A microcentrifuge (13,000 g)
(Eppendorf North America, Inc. Westbury, NY, USA),
water incubator (65°C), micropipette (20 ml and 500 ml
volume), and a vortex were also used throughout the
process.
All the isolation steps were carefully performed ac-
cording to the manufacturer’s instructions. After the last
step, genomic DNAs were obtained at the bottom of the
tubes and were stored at −20°C. Polymorphisms located
in the 1031 and 912 regions were detected and repro-
duced as described in Peres et al’s study [22].
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50 μM KCl, 1 μM of each primer, 200 μM of each dATP,
dCTP, dGTP, dTTP, 2.5 μM MgCl2, and 2.5 U Tag DNA
polymerase (Amerham Pharmacia Biotech, Uppsala,
Sweden).
The incubation process of the thermo cycle of the
PCR (Geneamp PCR systems 9700; Applied Biosystems,
Perkin – Elmer, Foster City, CA, USA) was performed as
follows: 5 min at 95°C, 10 cycles of the triple steps that
are 30 s at 95°C, 30 s at 60°C, and 30 s at 72°C; then an-
other 10 cycles of the triple steps that are 30 s at 95°C,
30 s at 58°C, and 30 s at 72°C; and finally 5 min at 72°C.
Gel electrophoresis
2% agarose (A5093, Sigma, St. Louis, MO, USA) was mixed
withTAE (Tris, acetic acid, and EDTA) solution and boiled
for 1 min to prepare agarose gel. 5 μl of the PCR product
was mixed with the loading dye and inserted into the pits.
The mixture was processed through gel electrophoresis
(Horizon 11–14; Life Technologies Inc., Paisley, Scotland)
for 45 minutes under 120 V. 100-bp DNA ladder was used
in the first pit of the gel. The 202-bp PCR product was
observed under a ultra-violet (UV) illuminator (TFX 20
M-Vilber Lourmat; Mar-na La Vallee, France) and
recorded.
Restriction enzyme digestion and genotyping
The rest of the 15-μl PCR product was used for restric-
tion enzyme digestion. A 6-μl mixture was prepared
consisting of 3.5 μl sterile dH2O, 2 μl of restriction en-
zyme buffer, and 0.5 μl restriction enzymes (HaeIII and
MseI). This mixture was added into the PCR product
and rested in a water bath at 37°C for 12–16 h.
A 3% agarose gel was prepared again, and the obtained
digestion product was loaded into this gel. A 100-bp
DNA ladder was added, and after 45 min at 120 V, the
bands were observed under a UV illuminator (TFX
20 M-Vilber Lourmat; Mar-na la Vallee, France).
Statistical analysis
Acquired data were statistically analyzed using the pro-
gram SPSS (version 15.0). The chi-square test was used,
and the power of significance of the data was tested.
Inter-group relations were evaluated using an odds ratio
(OR), and the results were arranged and shown in tables.
The significance level was given as 0.05.
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